Scancell Holdings PLC on Wednesday announced a major international biotechnology company will exclusively evaluate a Scancell investigational anti-glycan monoclonal antibody for development of novel...
CHIEF EXECUTIVE OFFICER'S STATEMENT
I am pleased to report the Group's interim results for the six-month period ended 31 October 2023. During the period, Scancell...
Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Presents data from first stage of Phase 2 Scope trial at 20th International Congress of the Society for Melanoma...
Net Asset Value Seneca Growth Capital VCT Plc 12 October 2023 Net Asset Value Update for the period ended 30 September 2023 The Directors and the Investment Manager of the Company, Seneca...
Net Asset Value(s) Seneca Growth Capital VCT Plc (the “Company”) 12 October 2023 Net Asset Value (“NAV”) Update for the period ended 30 September 2023 ...
The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:
----------
FTSE... | March 13, 2023